Nu Skin Enterprises (NUS) EBITDA Margin (2009 - 2026)

Nu Skin Enterprises has disclosed EBITDA Margin across 18 years of filings, most recently posting 18.53% for Q2 2026.

• In Q2 2026, EBITDA Margin fell 2650.0% year-over-year to 18.53%; the TTM figure through Jun 2026 stood at 0.76% (up 10.0% YoY), while the FY2025 annual figure was 4.43%, up 1318.0% from the prior year.
• EBITDA Margin came in at 18.53% for Q2 2026 at Nu Skin Enterprises, down from 1.26% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 9.19% in Q2 2022 to a low of 28.6% in Q2 2024.
• Average EBITDA Margin over 5 years is 0.27%, with a median of 3.31% recorded in 2023.
• Year-over-year, EBITDA Margin slumped 3709 bps in 2024 and surged 3657 bps in 2025.
• Over 5 years, EBITDA Margin stood at 5.26% in 2022, then slumped by 37 bps to 3.29% in 2023, then tumbled by 462 bps to 11.91% in 2024, then jumped by 153 bps to 6.28% in 2025, then plunged by 395 bps to 18.53% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 18.53% in Q2 2026, 1.26% in Q1 2026, and 6.28% in Q4 2025.